• Home
  • Overview
  • +2022 SABCS®
    • 2022 Symposium Overview
    • Call for Abstracts 2022
    • Preliminary Program 2022
    • +SABCS® Hotels
      • Shuttle Bus
      • Hotel Warning Alert
      • International Reservations
    • +SABCS® Registration
      • Group Registration
    • Patient Advocates
    • Support & Exhibits
    • Satellite Symposia
    • Media
    • +Travel & Transportation
      • Information for International Travelers
    • FAQs
  • +Resource Library
    • Past Meetings Press Releases
  • SABCS Podcast
  • Contact
  • Gallery
  • Best Of SABCS®
Media | Gallery | Contact
  • Home
  • Overview
  • 2022 SABCS®
    • 2022 Symposium Overview
    • Call for Abstracts 2022
    • Preliminary Program 2022
    • SABCS® Hotels
      • Shuttle Bus
      • Hotel Warning Alert
      • International Reservations
    • SABCS® Registration
      • Group Registration
    • Patient Advocates
    • Support & Exhibits
    • Satellite Symposia
    • Media
    • Travel & Transportation
      • Information for International Travelers
    • FAQs
  • Resource Library
    • Past Meetings Press Releases
  • SABCS Podcast
  • Contact
  • Gallery
  • Best Of SABCS®

Home  /   2021 SABCS®  /  2021 SABCS Program  /  Spotlight Sessions  /  Spotlight Poster Discussion 11

  • 2021 SABCS Updated Program Book
  • Schedule at a Glance

Daily Schedule:
  • Day 1: Tuesday, 12/7/2021
  • Day 2: Wednesday, 12/8/2021
  • Day 3: Thursday, 12/9/2021
  • Day 4: Friday, 12/10/2021
Poster Sessions:
  • Poster Session 1
  • Poster Session 2
  • Poster Session 3
  • Poster Session 4
  • Poster Session 5
  • Ongoing Trials Poster Session 1
  • Ongoing Trials Poster Session 2

Spotlight Sessions:

  • PD1 Endocrine Resistance: Novel mechanisms and emerging new therapies
  • PD2 Insights to CDK4/6i resistance: Novel models and clinical/translational genomics
  • PD3 Targets in Triple Negative Breast Cancer
  • PD4 Brain Metastases: Managing LMD / Targeting HER2
  • PD5 Life after breast cancer: Cardiac health, fertility preservation, and returning to life
  • PD6 Genomic and genetic analysis on metastases
  • PD7 Locoregional treatment: De-escalation in breast cancer
  • PD8 Novel therapies for HER2+ disease
  • PD9 Evaluating emerging and established biomarkers
  • PD10 Novel immunotherapy approaches
  • PD11 The future is now: Innovation in pathology and radiology
  • PD13 Novel therapeutics
  • PD14 Clinical translational updates in invasive lobular carcinoma
  • PD15 Defining molecular markers of endocrine resistance in clinic







  • Home
  • Symposium Overview
  • 2022 SABCS
  • Best of SABCS
  • Past Meetings
  • Media
  • Contact
7979 Wurzbach Road
MC 8224

San Antonio, Texas 78229, USA

SABCS@uthscsa.edu

210.450.1550

©2022 SABCS. All rights reserved.
Login